Annual EBITDA
$758.83M$264.97M-25.88%
Summary
- Current Value
- As of today, RDY annual EBITDA is $758.83M, down -25.88% on
- Historical Performance
- RDY annual EBITDA is down -5.96% over the past 3 years, up +25.67% over the past 5 years
- All-Time High Comparison
- RDY annual EBITDA is currently -25.88% below its historical high of $1.02B set on
- 3-Year Low Comparison
- RDY annual EBITDA is at its 3-year low
- Sector Comparison
- RDY annual EBITDA is higher than 92.25% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $758.83M | -25.9% | -6.0% | +25.7% | +120.5% | |
| Quarterly EBITDA | $66.00M | -72.1% | -65.7% | -52.3% | -32.0% | |
| TTM EBITDA | $767.37M | +2.3% | -4.3% | +27.2% | +123.0% | |
| Price | $13.63 | -7.6% | +25.1% | -4.5% | +91.2% | |
| PE Ratio | 23.19 | +25.9% | +43.6% | -54.8% | -7.1% | |
| Annual Revenue | $3.80B | -1.3% | +24.3% | +48.8% | +131.7% | |
| Annual EPS | $0.58 | -27.4% | -13.7% | +108.5% | +103.9% | |
| $525.62M | -36.1% | -19.1% | +21.8% | +107.8% | ||
| Annual Net Income | $480.61M | -29.0% | -14.3% | +107.0% | +98.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.02B | -25.9% | |
| 5Y | $1.02B | -25.9% | |
| All | $1.02B | -25.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $758.83M | at low | |
| 5Y | $603.81M | N/A | +25.7% |
| All | $11.77M | +6344.8% |
EBITDA History
FAQ
What is the current annual EBITDA of RDY?
As of today, RDY annual EBITDA is $758.83M
What is 1-year change in RDY annual EBITDA?
RDY annual EBITDA is down -25.88% year-over-year
What is 3-year change in RDY annual EBITDA?
RDY annual EBITDA is down -5.96% over the past 3 years
How far is RDY annual EBITDA from its all-time high?
RDY annual EBITDA is currently -25.88% below its historical high of $1.02B set on March 31, 2025
How does RDY annual EBITDA rank versus sector peers?
RDY annual EBITDA is higher than 92.25% of companies in Healthcare sector
When is RDY next annual earnings release?
As of today, the next annual earnings release for RDY has not been scheduled
Quarterly EBITDA
$66.00M$147.48M-69.08%
Summary
- Current Value
- As of today, RDY quarterly EBITDA is $66.00M, down -69.08% on
- Historical Performance
- RDY quarterly EBITDA is down -72.12% year-over-year, down -65.71% over the past 3 years
- All-Time High Comparison
- RDY quarterly EBITDA is currently -74.34% below its historical high of $257.18M set on
- 3-Year Low Comparison
- RDY quarterly EBITDA is at its 3-year low
- Sector Comparison
- RDY quarterly EBITDA is higher than 87.08% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $66.00M | -69.1% | -72.1% | -65.7% | -52.3% | |
| Annual EBITDA | $758.83M | – | -25.9% | -6.0% | +25.7% | |
| TTM EBITDA | $767.37M | -18.2% | +2.3% | -4.3% | +27.2% | |
| Price | $13.63 | -5.2% | -7.6% | +25.1% | -4.5% | |
| PE Ratio | 23.19 | +25.7% | +25.9% | +43.6% | -54.8% | |
| Quarterly Revenue | $821.02M | -16.2% | -16.4% | +7.2% | +26.6% | |
| Quarterly EPS | $0.03 | -82.3% | -86.9% | -79.4% | -51.8% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Quarterly Net Income | $24.09M | -82.0% | -86.9% | -79.3% | -51.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $252.46M | -73.9% | |
| 3Y | $257.18M | -74.3% | |
| 5Y | $257.18M | -74.3% | |
| All | $257.18M | -74.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $66.00M | at low | |
| 3Y | $66.00M | at low | |
| 5Y | $66.00M | at low | |
| All | $1.46M | +4408.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RDY?
As of today, RDY quarterly EBITDA is $66.00M
What is RDY quarterly EBITDA most recent change?
RDY quarterly EBITDA was down -69.08% on March 31, 2026
What is 1-year change in RDY quarterly EBITDA?
RDY quarterly EBITDA is down -72.12% year-over-year
How far is RDY quarterly EBITDA from its all-time high?
RDY quarterly EBITDA is currently -74.34% below its historical high of $257.18M set on September 30, 2024
How does RDY quarterly EBITDA rank versus sector peers?
RDY quarterly EBITDA is higher than 87.08% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
TTM EBITDA
$767.37M$170.71M-18.20%
Summary
- Current Value
- As of today, RDY TTM EBITDA is $767.37M, down -18.20% on
- Historical Performance
- RDY TTM EBITDA is up +2.34% year-over-year, down -4.27% over the past 3 years
- All-Time High Comparison
- RDY TTM EBITDA is currently -21.00% below its historical high of $971.34M set on
- 3-Year Low Comparison
- RDY TTM EBITDA is +5.90% above its 3-year low of $724.60M reached on
- Sector Comparison
- RDY TTM EBITDA is higher than 91.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $767.37M | -18.2% | +2.3% | -4.3% | +27.2% | |
| Annual EBITDA | $758.83M | – | -25.9% | -6.0% | +25.7% | |
| Quarterly EBITDA | $66.00M | -69.1% | -72.1% | -65.7% | -52.3% | |
| Price | $13.63 | -5.2% | -7.6% | +25.1% | -4.5% | |
| PE Ratio | 23.19 | +25.7% | +25.9% | +43.6% | -54.8% | |
| TTM Revenue | $3.81B | -4.0% | -1.1% | +24.6% | +48.9% | |
| TTM EPS | $0.59 | -24.6% | -26.6% | -12.9% | +111.3% | |
| $528.06M | -25.9% | -34.9% | -18.0% | +22.6% | ||
| TTM Net Income | $485.75M | -24.7% | -28.2% | -13.5% | +110.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $938.08M | -18.2% | |
| 3Y | $971.34M | -21.0% | |
| 5Y | $971.34M | -21.0% | |
| All | $971.34M | -21.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $724.60M | +5.9% | |
| 3Y | $724.60M | +5.9% | |
| 5Y | $579.16M | +32.5% | |
| All | $15.84M | +4743.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RDY?
As of today, RDY TTM EBITDA is $767.37M
What is RDY TTM EBITDA most recent change?
RDY TTM EBITDA was down -18.20% on March 31, 2026
What is 1-year change in RDY TTM EBITDA?
RDY TTM EBITDA is up +2.34% year-over-year
How far is RDY TTM EBITDA from its all-time high?
RDY TTM EBITDA is currently -21.00% below its historical high of $971.34M set on September 30, 2024
How does RDY TTM EBITDA rank versus sector peers?
RDY TTM EBITDA is higher than 91.88% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RDY Official Website www.drreddys.com
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy